[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CurrentPartnering Discusses Colorectal Cancer Partnering

13 Mar 2012 • by Natalie Aster

The majority of deals within the colorectal cancer are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors colorectal cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.

The “Colorectal Cancer Partnering 2007-2012” by CurrentPartnering provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of colorectal cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors colorectal cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Report Details:

Colorectal Cancer Partnering 2007-2012
Published: February, 2012
Pages: 200
Price: US$ 995,00

This data driven report contains over 150 links to online copies of actual colorectal cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

More information can be found in the report “Colorectal Cancer Partnering 2007-2012” by CurrentPartnering.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com

 

Analytics & News

Weekly Digest